Examination of quality of life in patients using exenatide with different dimensions
Objective: To investigate the effects of exenatide treatment on type-2 diabetes mellitus patients’ quality of life. Methods: The cross-sectional study was conducted from March 1 to June 30, 2019, after approval from Suleyman Demirel University, Isparta, Turkey, and comprised type 2 diabetes melli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pakistan Medical Association
2022-05-01
|
| Series: | Journal of the Pakistan Medical Association |
| Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/395 |
| _version_ | 1797820837865193472 |
|---|---|
| author | Siddika Ersoy Ismail Hakki Ersoy Sukran Ozkahraman-Koc |
| author_facet | Siddika Ersoy Ismail Hakki Ersoy Sukran Ozkahraman-Koc |
| author_sort | Siddika Ersoy |
| collection | DOAJ |
| description |
Objective: To investigate the effects of exenatide treatment on type-2 diabetes mellitus patients’ quality of life.
Methods: The cross-sectional study was conducted from March 1 to June 30, 2019, after approval from Suleyman Demirel University, Isparta, Turkey, and comprised type 2 diabetes mellitus patients of either gender under exenatide treatment. Data was collected using a questionnaire during face-to-face interview and included sociodemographic and clinical information along with the World Health Organisation-5 well-being index, the obesity awareness and insight scale, the obesity-specific quality of life scale and the coping orientation to problems experienced-brief inventory. Data was analysed using SPSS 22.
Results: Of the 146 patients, 82(56.2%) were female. The overall mean age was 50.6±11.5 years, mean duration of diabetes was 7.4±4.3 years, and mean exenatide use was 9.1±6.6 months. The most common reason cited in favour of exenatide was related to weight-loss 121(82.9%). The patients scored the highest score on the ‘Awareness’ subscale of the obesity awareness scale 29.54±5.42.
Conclusion: Exenatide use was effective in improving quality of life, and weight-loss was considered a secondary gain by the diabetics.
Key Words: Diabetes mellitus, Exenatide, Quality of life, Patients.
|
| first_indexed | 2024-03-13T09:44:13Z |
| format | Article |
| id | doaj.art-2338830071fa4fad99c5663d4a5ba326 |
| institution | Directory Open Access Journal |
| issn | 0030-9982 |
| language | English |
| last_indexed | 2024-03-13T09:44:13Z |
| publishDate | 2022-05-01 |
| publisher | Pakistan Medical Association |
| record_format | Article |
| series | Journal of the Pakistan Medical Association |
| spelling | doaj.art-2338830071fa4fad99c5663d4a5ba3262023-05-25T04:22:08ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822022-05-0172510.47391/JPMA.0395Examination of quality of life in patients using exenatide with different dimensionsSiddika Ersoy0Ismail Hakki Ersoy1Sukran Ozkahraman-Koc2Department of Nursing, Suleyman Demirel University, Isparta, TurkeyDepartment of Internal Medicine, Isparta City Hospital, Isparta, TurkeyDepartment of Midwifery, Suleyman Demirel University, Isparta, Turkey Objective: To investigate the effects of exenatide treatment on type-2 diabetes mellitus patients’ quality of life. Methods: The cross-sectional study was conducted from March 1 to June 30, 2019, after approval from Suleyman Demirel University, Isparta, Turkey, and comprised type 2 diabetes mellitus patients of either gender under exenatide treatment. Data was collected using a questionnaire during face-to-face interview and included sociodemographic and clinical information along with the World Health Organisation-5 well-being index, the obesity awareness and insight scale, the obesity-specific quality of life scale and the coping orientation to problems experienced-brief inventory. Data was analysed using SPSS 22. Results: Of the 146 patients, 82(56.2%) were female. The overall mean age was 50.6±11.5 years, mean duration of diabetes was 7.4±4.3 years, and mean exenatide use was 9.1±6.6 months. The most common reason cited in favour of exenatide was related to weight-loss 121(82.9%). The patients scored the highest score on the ‘Awareness’ subscale of the obesity awareness scale 29.54±5.42. Conclusion: Exenatide use was effective in improving quality of life, and weight-loss was considered a secondary gain by the diabetics. Key Words: Diabetes mellitus, Exenatide, Quality of life, Patients. https://www.ojs.jpma.org.pk/index.php/public_html/article/view/395 |
| spellingShingle | Siddika Ersoy Ismail Hakki Ersoy Sukran Ozkahraman-Koc Examination of quality of life in patients using exenatide with different dimensions Journal of the Pakistan Medical Association |
| title | Examination of quality of life in patients using exenatide with different dimensions |
| title_full | Examination of quality of life in patients using exenatide with different dimensions |
| title_fullStr | Examination of quality of life in patients using exenatide with different dimensions |
| title_full_unstemmed | Examination of quality of life in patients using exenatide with different dimensions |
| title_short | Examination of quality of life in patients using exenatide with different dimensions |
| title_sort | examination of quality of life in patients using exenatide with different dimensions |
| url | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/395 |
| work_keys_str_mv | AT siddikaersoy examinationofqualityoflifeinpatientsusingexenatidewithdifferentdimensions AT ismailhakkiersoy examinationofqualityoflifeinpatientsusingexenatidewithdifferentdimensions AT sukranozkahramankoc examinationofqualityoflifeinpatientsusingexenatidewithdifferentdimensions |